Cite
HARVARD Citation
Villablanca, J. et al. (2018). Predictors of response, progression‐free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high‐risk neuroblastoma. Pediatric blood & cancer. 65 (5), p. n/a. [Online].